Henry Horhey

Doctor of Osteopathic Medicine,  Mayo Clinic - Rochester 

Location: Africa

Consulting Services

Data Science-Bioinformatics Journal Manuscript Research Consulting IT-Web-Mobile Technology Grant Submission

Areas Of Interest

Angiogenesis, Physiologic Pericarditis, Constrictive Cosmic Dusts Whole-Body Radiations Orientation, Psychological Therapy, Horticultural Saccule and Utricle Breathing Work Public Health Nurses Ligustrums Proteins c-fyn, Proto-Oncogene Professional-Patient Disagreements Chronic Arthritis, Juvenile Science, Biomimicry Statements, Expense Proportional Hazard Model Cobrotoxin CREM Protein, epsilon Isoform Cdk4 Cyclin-Dependent Kinase Npn-2 Protein NSC-141540 Luciferase Blattodeas Artemisias Hypertonia, Infantile Gait, Frontal PPARdelta Life, Food Shelf Myelinoclastic Diffuse Sclerosis Relations, Family Regional Anesthesia Nephrostomies Kinase, AMP Ergometrine Maleate Monoclonal Antibodies, Antineoplastic Biphenabid Heteropteras Dystrophies, Progressive Tapetochoroidal Dysplasias, Multicystic Renal Communications, Animal Sound

Professional Narrative

Dr. Henry Horhey was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Horhey has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Medical Writer, Mayo Clinic 2002
Director Medicine, Mayo Clinic 1994

Education

Master of Science in physician assistant, Yale School of Medicine 2001
Doctor of medicine, Baylor College 2007

Referees

Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02